Graham, J;
Banaschewski, T;
Buitelaar, J;
Coghill, D;
Danckaerts, M;
Dittmann, RW;
Döpfner, M;
... Taylor, E; + view all
(2010)
European guidelines on managing adverse effects of medication for ADHD.
European Child & Adolescent Psychiatry
, 20
(1)
17 - 37.
10.1007/s00787-010-0140-6.
![[thumbnail of art%253A10.1007%252Fs00787-010-0140-6.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) Preview |
Text
art%253A10.1007%252Fs00787-010-0140-6.pdf Download (445kB) |
Abstract
The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical subspecialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks.
| Type: | Article |
|---|---|
| Title: | European guidelines on managing adverse effects of medication for ADHD. |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1007/s00787-010-0140-6 |
| Publisher version: | http://dx.doi.org/10.1007/s00787-010-0140-6 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1358653 |
Archive Staff Only
 |
View Item |
